BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12503275)

  • 21. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zantac (ranitidine) in treating duodenal ulcers].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2002; (3):68-70, 121. PubMed ID: 12353395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
    Onoda N; Katsuragi K; Sawada T; Maeda K; Mino A; Ohira M; Ishikawa T; Wakasa K; Hirakawa K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):515-21. PubMed ID: 16471313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
    Neuhann HF; Swai B; Carpenter CF; Shao O
    Trop Doct; 2003 Oct; 33(4):225-8. PubMed ID: 14620428
    [No Abstract]   [Full Text] [Related]  

  • 27. [H. pylori and chronic duodenal ulcer: eradication therapy with ranitidine-antibiotic combination and follow-up of ulcer disease].
    Holtmann G; Layer P
    Z Gastroenterol; 1994 Aug; 32(8):474-5. PubMed ID: 7975793
    [No Abstract]   [Full Text] [Related]  

  • 28. [24-hour monitoring of gastric juice pH in assessment of anti-ulcer treatment].
    Maev IV; Andreev NG; Val'tsova ED; Romashkina MA; Ismailova MZ
    Ter Arkh; 2000; 72(2):8-11. PubMed ID: 10717914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
    Urakami Y; Sano T
    J Med Invest; 2003 Feb; 50(1-2):48-54. PubMed ID: 12630568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis.
    Veereman Wauters G; Ferrell L; Ostroff JW; Heyman MB
    Am J Gastroenterol; 1990 Oct; 85(10):1395-7. PubMed ID: 2220735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
    Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
    Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism.
    Chey WD; Woods M; Scheiman JM; Nostrant TT; DelValle J
    Am J Gastroenterol; 1997 Mar; 92(3):446-50. PubMed ID: 9068466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
    Pellegrini M; Urso R; Giorgi G; Bayeli PF; Marzocca G; Cerretani D
    Aliment Pharmacol Ther; 2005 Aug; 22(4):343-8. PubMed ID: 16098001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Regression of primary gastric lymphoma after treatment with ranitidine].
    Tassinari D; Sartori S; Cangiotti C; Gianni L; Rinaldi P; Ravaioli A; Iorio D
    Recenti Prog Med; 1997 Apr; 88(4):179-80. PubMed ID: 9206815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.